Dr. Ghulam Md Ashraf is working as an Associate Professor in the Department of Medical Laboratory Sciences, College of Health Sciences, and Sharjah Institute for Medical Research, University of Sharjah, Sharjah United Arab Emirates. He has a PhD degree in Biochemistry with over twelve years of teaching and research experience in various disciplines of biological and medical sciences. Dr. Ashraf has taught various subjects like Biochemistry, Biology, Clinical Biochemistry, Cell Biology, Genetics, Immunology, Intellectual Property Rights, Introduction to Research, Molecular Biology, Neurology, Recombinant DNA, and Research Methods Technology at graduate and post-graduate levels. His primary fields of research are biochemistry and neurology, currently focusing on understanding the molecular and behavioral mechanism of effects of anti-diabetic drugs in pyschotic and dementia conditions. Dr. Ashraf’s lab is currently investigating the effect of anti-diabetic drugs in the possible attenuation/reversal of anti-psychotic drugs induced weight gain in psychotic conditions. He is also investigating molecular and behavioral mechanisms of novel therapeutic combinations in multiple sclerosis and Alzheimer’s disease. Dr. Ashraf has published 398 research articles (citations: 9928, H-index: 53, i10 index: 208) and have been involved in 25 research grants [4 ongoing (1 PI, 3 CoI) and 21 completed (17 PI, 4 CoI)]. He has supervised 3 PhD, 2 masters and 7 bachelor students in their research projects. Dr. Ashraf has served as examiner of 9 PhD and master theses and have assessed 4 research grant applications. Dr. Ashraf is also involved extensively in editorial roles in renowned scientific journals like Journal of Advanced Research (Associate Editor), Scientific Reports (Senior EBM), PLoS One (Academic Editor), Current Neuropharmacology (Section Editor) and Disease Markers (Academic Editor). He has to his credit 359 Publons verified editor records, and 609 Publons verified reviewer records. Dr. Ashraf has been involved as guest editor of 21 special issues in reputed international journals. He is professionally associated with the Royal Society of Medicine (Fellow), Royal Society of Biology (Member), American Society for Biochemistry and Molecular Biology (Member) and Canadian Association of Neuroscience (Member).For his scientific contributions, Dr. Ashraf was approved as a subject of biographical record in Marquis Who's Who in the World (2020). Dr. Ashraf has been recognized as Expertscape World Expert in Alzheimer’s disease and Neurodegenerative Disorders. Most recently, he has been listed in Top 2% Scientists Worldwide for two consecutive years (2020 and 2021), announced by Stanford-Elsevier BV (Baas et al., 2021).Orcid: https://orcid.org/0000-0002-9820-2078Scopus: https://www.scopus.com/authid/detail.uri?authorId=16444016700Web of Science: https://www.webofscience.com/wos/author/record/H-9485-2012Google scholar: http://scholar.google.com/citations?user=-fOCOTQAAAAJ&hl=en

• Section I. Transmitters and SystemsChapter 1: Adrenergic NeurotransmissionChapter 2: Cholinergic NeurotransmissionChapter 3: Dopamine SignalingSection II. Neurochemical Signaling and PathologiesChapter 4: Neurochemical Signaling in Alzheimer’s DiseaseChapter 5: Alzheimer’s Disease: Pathogenesis and Therapeutics Advancements Targeting Potential Neurotransmitters and Neuronal PeptidesChapter 6: Cholinergic Neurotransmission System: Signaling Pathways and Their Role in Parkinson’s DiseaseChapter 7: Neurochemical Alterations in Parkinson's DiseaseChapter 8: Therapeutic Targets and Neurochemical Signaling in Huntington’s DiseaseChapter 9: Schizophrenia: Neurochemical Insight into a Mind’s Faulty DimensionChapter 10: Neurochemical Signaling in Depression: Impact of Target-Based PharmaceuticalsChapter 11: Role of Endocannabinoids in Neurocognitive DysfunctionsChapter 12: Role of Glutaminergic System in SchizophreniaChapter 13: Mania: Developmental Considerations from Diagnosis to TreatmentChapter 14: Myasthenia Gravis: Molecular Pathogenesis and Therapeutic AdvancesSection III. Typical Neurochemical Processes Chapter 15: Neurogenesis in the Embryonic and Adult BrainChapter 16: Neuronal Proliferation and Associated DiseasesChapter 17: Neurobiology in Correlation with Romantic AttractionChapter 18: Neurobiology of love: A Comprehensive Analysis

Dr. Ghulam Md Ashraf is working as an Associate Professor in the Department of Medical Laboratory Sciences, College of Health Sciences, and Sharjah Institute for Medical Research, University of Sharjah, Sharjah United Arab Emirates. He has a PhD degree in Biochemistry with over twelve years of teaching and research experience in various disciplines of biological and medical sciences. Dr. Ashraf has taught various subjects like Biochemistry, Biology, Clinical Biochemistry, Cell Biology, Genetics, Immunology, Intellectual Property Rights, Introduction to Research, Molecular Biology, Neurology, Recombinant DNA, and Research Methods Technology at graduate and post-graduate levels. His primary fields of research are biochemistry and neurology, currently focusing on understanding the molecular and behavioral mechanism of effects of anti-diabetic drugs in pyschotic and dementia conditions. Dr. Ashraf’s lab is currently investigating the effect of anti-diabetic drugs in the possible attenuation/reversal of anti-psychotic drugs induced weight gain in psychotic conditions. He is also investigating molecular and behavioral mechanisms of novel therapeutic combinations in multiple sclerosis and Alzheimer’s disease. Dr. Ashraf has published 398 research articles (citations: 9928, H-index: 53, i10 index: 208) and have been involved in 25 research grants [4 ongoing (1 PI, 3 CoI) and 21 completed (17 PI, 4 CoI)]. He has supervised 3 PhD, 2 masters and 7 bachelor students in their research projects. Dr. Ashraf has served as examiner of 9 PhD and master theses and have assessed 4 research grant applications. Dr. Ashraf is also involved extensively in editorial roles in renowned scientific journals like Journal of Advanced Research (Associate Editor), Scientific Reports (Senior EBM), PLoS One (Academic Editor), Current Neuropharmacology (Section Editor) and Disease Markers (Academic Editor). He has to his credit 359 Publons verified editor records, and 609 Publons verified reviewer records. Dr. Ashraf has been involved as guest editor of 21 special issues in reputed international journals. He is professionally associated with the Royal Society of Medicine (Fellow), Royal Society of Biology (Member), American Society for Biochemistry and Molecular Biology (Member) and Canadian Association of Neuroscience (Member).For his scientific contributions, Dr. Ashraf was approved as a subject of biographical record in Marquis Who's Who in the World (2020). Dr. Ashraf has been recognized as Expertscape World Expert in Alzheimer’s disease and Neurodegenerative Disorders. Most recently, he has been listed in Top 2% Scientists Worldwide for two consecutive years (2020 and 2021), announced by Stanford-Elsevier BV (Baas et al., 2021).Orcid: https://orcid.org/0000-0002-9820-2078Scopus: https://www.scopus.com/authid/detail.uri?authorId=16444016700Web of Science: https://www.webofscience.com/wos/author/record/H-9485-2012Google scholar: http://scholar.google.com/citations?user=-fOCOTQAAAAJ&hl=en

• Section I. Transmitters and SystemsChapter 1: Adrenergic NeurotransmissionChapter 2: Cholinergic NeurotransmissionChapter 3: Dopamine SignalingSection II. Neurochemical Signaling and PathologiesChapter 4: Neurochemical Signaling in Alzheimer’s DiseaseChapter 5: Alzheimer’s Disease: Pathogenesis and Therapeutics Advancements Targeting Potential Neurotransmitters and Neuronal PeptidesChapter 6: Cholinergic Neurotransmission System: Signaling Pathways and Their Role in Parkinson’s DiseaseChapter 7: Neurochemical Alterations in Parkinson's DiseaseChapter 8: Therapeutic Targets and Neurochemical Signaling in Huntington’s DiseaseChapter 9: Schizophrenia: Neurochemical Insight into a Mind’s Faulty DimensionChapter 10: Neurochemical Signaling in Depression: Impact of Target-Based PharmaceuticalsChapter 11: Role of Endocannabinoids in Neurocognitive DysfunctionsChapter 12: Role of Glutaminergic System in SchizophreniaChapter 13: Mania: Developmental Considerations from Diagnosis to TreatmentChapter 14: Myasthenia Gravis: Molecular Pathogenesis and Therapeutic AdvancesSection III. Typical Neurochemical Processes Chapter 15: Neurogenesis in the Embryonic and Adult BrainChapter 16: Neuronal Proliferation and Associated DiseasesChapter 17: Neurobiology in Correlation with Romantic AttractionChapter 18: Neurobiology of love: A Comprehensive Analysis

Dr. Ghulam Md Ashraf is working as an Associate Professor in the Department of Medical Laboratory Sciences, College of Health Sciences, and Sharjah Institute for Medical Research, University of Sharjah, Sharjah United Arab Emirates. He has a PhD degree in Biochemistry with over twelve years of teaching and research experience in various disciplines of biological and medical sciences. Dr. Ashraf has taught various subjects like Biochemistry, Biology, Clinical Biochemistry, Cell Biology, Genetics, Immunology, Intellectual Property Rights, Introduction to Research, Molecular Biology, Neurology, Recombinant DNA, and Research Methods Technology at graduate and post-graduate levels. His primary fields of research are biochemistry and neurology, currently focusing on understanding the molecular and behavioral mechanism of effects of anti-diabetic drugs in pyschotic and dementia conditions. Dr. Ashraf’s lab is currently investigating the effect of anti-diabetic drugs in the possible attenuation/reversal of anti-psychotic drugs induced weight gain in psychotic conditions. He is also investigating molecular and behavioral mechanisms of novel therapeutic combinations in multiple sclerosis and Alzheimer’s disease. Dr. Ashraf has published 398 research articles (citations: 9928, H-index: 53, i10 index: 208) and have been involved in 25 research grants [4 ongoing (1 PI, 3 CoI) and 21 completed (17 PI, 4 CoI)]. He has supervised 3 PhD, 2 masters and 7 bachelor students in their research projects. Dr. Ashraf has served as examiner of 9 PhD and master theses and have assessed 4 research grant applications. Dr. Ashraf is also involved extensively in editorial roles in renowned scientific journals like Journal of Advanced Research (Associate Editor), Scientific Reports (Senior EBM), PLoS One (Academic Editor), Current Neuropharmacology (Section Editor) and Disease Markers (Academic Editor). He has to his credit 359 Publons verified editor records, and 609 Publons verified reviewer records. Dr. Ashraf has been involved as guest editor of 21 special issues in reputed international journals. He is professionally associated with the Royal Society of Medicine (Fellow), Royal Society of Biology (Member), American Society for Biochemistry and Molecular Biology (Member) and Canadian Association of Neuroscience (Member).For his scientific contributions, Dr. Ashraf was approved as a subject of biographical record in Marquis Who's Who in the World (2020). Dr. Ashraf has been recognized as Expertscape World Expert in Alzheimer’s disease and Neurodegenerative Disorders. Most recently, he has been listed in Top 2% Scientists Worldwide for two consecutive years (2020 and 2021), announced by Stanford-Elsevier BV (Baas et al., 2021).Orcid: https://orcid.org/0000-0002-9820-2078Scopus: https://www.scopus.com/authid/detail.uri?authorId=16444016700Web of Science: https://www.webofscience.com/wos/author/record/H-9485-2012Google scholar: http://scholar.google.com/citations?user=-fOCOTQAAAAJ&hl=en

• Section I. Transmitters and SystemsChapter 1: Adrenergic NeurotransmissionChapter 2: Cholinergic NeurotransmissionChapter 3: Dopamine SignalingSection II. Neurochemical Signaling and PathologiesChapter 4: Neurochemical Signaling in Alzheimer’s DiseaseChapter 5: Alzheimer’s Disease: Pathogenesis and Therapeutics Advancements Targeting Potential Neurotransmitters and Neuronal PeptidesChapter 6: Cholinergic Neurotransmission System: Signaling Pathways and Their Role in Parkinson’s DiseaseChapter 7: Neurochemical Alterations in Parkinson's DiseaseChapter 8: Therapeutic Targets and Neurochemical Signaling in Huntington’s DiseaseChapter 9: Schizophrenia: Neurochemical Insight into a Mind’s Faulty DimensionChapter 10: Neurochemical Signaling in Depression: Impact of Target-Based PharmaceuticalsChapter 11: Role of Endocannabinoids in Neurocognitive DysfunctionsChapter 12: Role of Glutaminergic System in SchizophreniaChapter 13: Mania: Developmental Considerations from Diagnosis to TreatmentChapter 14: Myasthenia Gravis: Molecular Pathogenesis and Therapeutic AdvancesSection III. Typical Neurochemical Processes Chapter 15: Neurogenesis in the Embryonic and Adult BrainChapter 16: Neuronal Proliferation and Associated DiseasesChapter 17: Neurobiology in Correlation with Romantic AttractionChapter 18: Neurobiology of love: A Comprehensive Analysis